What should be done for a 12-week-old infant who received the first dose of the DTap (Diphtheria, Tetanus, and Pertussis)/ipv (inactivated poliovirus)/hib (Haemophilus influenzae type b), hepatitis combined vaccine as per the NHS protocol in one location and is now in another location?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 21, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Continuing Vaccination After Relocation

Continue the vaccination series according to the current location's schedule without repeating the first dose, as interrupted or delayed vaccination series do not require restarting. 1

Core Principle: No Need to Restart Series

  • Vaccination series interrupted by relocation should be continued at the next clinic visit without repeating doses. 1
  • The specific brand or formulation used for the first dose does not necessitate restarting, though using the same manufacturer's product throughout is preferred when feasible. 2
  • Any valid dose of DTaP-containing combination vaccine counts toward completion of the series, regardless of where it was administered. 2

Recommended Action at 12 Weeks

At 12 weeks of age, administer the second dose of the DTaP/IPV/Hib/Hepatitis B combination vaccine series according to the standard schedule. 3

Standard Timing for Second Dose:

  • The second dose should be given at approximately 2 months (8 weeks) of age, with a minimum interval of 4 weeks between doses. 2, 3
  • Since this infant is already 12 weeks old, the second dose should be administered immediately at the current visit. 3
  • The minimum age for DTaP, IPV, and Hib vaccines is 6 weeks, which this infant has exceeded. 3

Complete Vaccination Schedule Going Forward

Remaining Primary Series:

  • Third dose at 6 months of age (minimum 4-week interval from second dose, though 8 weeks is preferred). 2
  • Fourth dose (booster) at 15-18 months of age (minimum 6 months after third dose). 4, 2
  • Final DTaP dose at 4-6 years of age. 2

Component-Specific Considerations:

Hepatitis B:

  • The second dose should be given at 1-2 months of age (already overdue at 12 weeks). 2
  • The third dose must be administered at ≥24 weeks of age with at least 8 weeks after the second dose. 2

Hib:

  • If using PRP-OMP conjugate (PedvaxHIB), only 2 primary doses are needed at 2 and 4 months, followed by a booster at 12-15 months. 1, 2
  • If using HbOC or PRP-T conjugates, 3 primary doses are needed (2,4,6 months) plus booster at 12-15 months. 2
  • The booster must be given at least 2 months after the last primary dose. 2

IPV:

  • Four total doses are recommended at 2,4,6-18 months, and 4-6 years. 2
  • Minimum 4-week intervals between doses are acceptable for catch-up schedules. 2

Critical Timing Considerations

Rotavirus Vaccine Window:

  • If rotavirus vaccine was not given with the first dose, it can still be initiated up to 12 weeks of age. 3
  • At exactly 12 weeks, this is the last opportunity to start the rotavirus series. 3
  • The first dose must be given between 6-12 weeks; the series cannot be started after 12 weeks of age. 2, 3

Interchangeability of Vaccines

  • Different brands of DTaP-containing combination vaccines can be used interchangeably to complete the series. 2, 1
  • While using the same manufacturer's product throughout is preferred, vaccination should not be delayed if the original brand is unavailable. 2
  • Any inadvertently administered dose (even if wrong brand or given at >5 years) should be counted as valid. 2

Documentation and Monitoring

  • Obtain complete vaccination records from the NHS location to verify the exact vaccine product and date of first dose. 2
  • Local reactions (pain, redness, swelling) increase with subsequent doses, particularly after the 4th and 5th doses, primarily due to the pertussis component. 5
  • Monitor for increased local reactions at the injection site, which are typically mild and self-limited. 5

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Vaccination Guidelines for Infants

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Vaccination Schedule for 18 Months

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Risks of an Extra Dose of Pediarix

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

What are the recommended vaccinations and developmental milestones for a 6-month well-child checkup?
What are the key components of a 6-month well child check, including assessments, vaccinations such as DTaP (diphtheria, tetanus, and pertussis), Hib (Haemophilus influenzae type b), IPV (inactivated poliovirus), and PCV (pneumococcal conjugate vaccine), safety evaluations, and monitoring for a healthy 6-month-old child?
What are the expected developmental milestones at a 9-month well-child check?
What vaccinations are necessary for a 9-month-old child with no previous vaccinations, presenting to a well-baby clinic?
What vaccines are recommended for a 4-month-old infant with concurrent antibiotic use?
What is the clinical significance and treatment approach for a patient with a known Five Factor Score, diagnosed with myelodysplastic syndromes (MDS) or acute myeloid leukemia (AML)?
What magnesium salt is recommended for treating constipation in adults, including geriatric individuals, with impaired renal function or those taking interacting medications?
What are the treatment options for a 40-60 year old man with Peyronie's disease?
What are the treatment options for a patient with liver parenchymal disease, potentially with underlying hepatitis B or C infection, or non-alcoholic fatty liver disease?
Can a 12-week-old infant who received the first dose of a DTaP (Diphtheria, Tetanus, and Pertussis)/IPV (Inactivated Poliovirus)/Hib (Haemophilus influenzae type b)/Hepatitis B combined vaccine in one location be given a different hexavalent vaccine in another location to complete the series?
Is Spironolactone (potassium-sparing diuretic) safe to use during pregnancy, especially in a patient with a history of heart failure or fluid retention?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.